{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:47:43Z","timestamp":1791856063729,"version":"4.3.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005941","name":"Dietmar Hopp Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005941","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.gim.2024.101303","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T14:49:21Z","timestamp":1729262961000},"page":"101303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Impact of early diagnosis, disease variant, and quality of care on the neurocognitive outcome in maple syrup urine disease: A meta-analysis"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2619-8727","authenticated-orcid":false,"given":"Svenja","family":"Scharre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Mengler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Schnabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oya","family":"Kuseyri H\u00fcbschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Tun\u00e7","family":"Tuncel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg Friedrich","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven F.","family":"Garbade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"M\u00fctze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"K\u00f6lker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gim.2024.101303_bib1","series-title":"GeneReviews\u00ae","first-page":"1","article-title":"Maple syrup urine disease","author":"Strauss","year":"2006"},{"issue":"6","key":"10.1016\/j.gim.2024.101303_bib2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s10545-006-0276-1","article-title":"Variant maple syrup urine disease (MSUD)\u2014the entire spectrum","volume":"29","author":"Simon","year":"2006","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"6","key":"10.1016\/j.gim.2024.101303_bib3","first-page":"1531S","article-title":"Brain amino acid requirements and toxicity: the example of leucine","volume":"135","author":"Yudkoff","year":"2005","journal-title":"J\u00a0Nutr"},{"issue":"3","key":"10.1016\/j.gim.2024.101303_bib4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ymgme.2014.05.006","article-title":"Nutrition management guideline for maple syrup urine disease: an evidence- and consensus-based approach","volume":"112","author":"Frazier","year":"2014","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.1016\/j.gim.2024.101303_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ymgme.2020.01.006","article-title":"Branched-chain alpha-ketoacid dehydrogenase deficiency (maple syrup urine disease): treatment, biomarkers, and outcomes","volume":"129","author":"Strauss","year":"2020","journal-title":"Mol Genet Metab"},{"issue":"6","key":"10.1016\/j.gim.2024.101303_bib6","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/lt.25423","article-title":"Surgical aspects of liver transplantation and domino liver transplantation in maple syrup urine disease: analysis of 15 donor-recipient pairs","volume":"25","author":"Herden","year":"2019","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.gim.2024.101303_bib7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jpeds.2011.06.033","article-title":"Liver transplantation for classical maple syrup urine disease: long-term follow-up in 37 patients and comparative United Network for Organ Sharing experience","volume":"160","author":"Mazariegos","year":"2012","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.gim.2024.101303_bib8","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ejpn.2015.07.009","article-title":"Evolution of maple syrup urine disease in patients diagnosed by newborn screening versus late diagnosis","volume":"19","author":"Couce","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"issue":"1","key":"10.1016\/j.gim.2024.101303_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ajmg.c.20003","article-title":"Genetic heritage of the Old Order Mennonites of southeastern Pennsylvania","volume":"121C","author":"Puffenberger","year":"2003","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"1","key":"10.1016\/j.gim.2024.101303_bib11","first-page":"9","article-title":"Challenges in the management of patients with maple syrup urine disease diagnosed by newborn screening in a developing country","volume":"8","author":"De Castro-Hamoy","year":"2017","journal-title":"J\u00a0Community Genet"},{"issue":"3","key":"10.1016\/j.gim.2024.101303_bib12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/jimd.12337","article-title":"Maple syrup urine disease: clinical outcomes, metabolic control, and genotypes in a screened population after four decades of newborn bloodspot screening in the Republic of Ireland","volume":"44","author":"O\u2019Reilly","year":"2021","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"4","key":"10.1016\/j.gim.2024.101303_bib13","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s10545-006-0315-y","article-title":"Maple syrup urine disease: favourable effect of early diagnosis by newborn screening on the neonatal course of the disease","volume":"29","author":"Simon","year":"2006","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"5","key":"10.1016\/j.gim.2024.101303_bib14","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-0444","article-title":"Long-term outcomes of individuals with metabolic diseases identified through newborn screening","volume":"146","author":"M\u00fctze","year":"2020","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.gim.2024.101303_bib15","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-064370","article-title":"Treatment outcomes for maple syrup urine disease detected by newborn screening","volume":"154","author":"Mengler","year":"2024","journal-title":"Pediatrics"},{"key":"10.1016\/j.gim.2024.101303_bib16","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1 Pt 1","key":"10.1016\/j.gim.2024.101303_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0022-3476(05)81037-6","article-title":"Intellectual outcome in children with maple syrup urine disease","volume":"119","author":"Kaplan","year":"1991","journal-title":"J\u00a0Pediatr"},{"issue":"suppl 2","key":"10.1016\/j.gim.2024.101303_bib18","first-page":"735","article-title":"[Heterogeneity of leucinosis. Correlations between clinical manifestations, protein tolerance and enzyme deficiency]","volume":"39","author":"Saudubray","year":"1982","journal-title":"Arch Fr P\u00e9diatr"},{"issue":"3","key":"10.1016\/j.gim.2024.101303_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10545-017-0033-7","article-title":"Neurocognitive profiles in MSUD school-age patients","volume":"40","author":"Bouchereau","year":"2017","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"13-14","key":"10.1016\/j.gim.2024.101303_bib20","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.cca.2012.03.014","article-title":"Amino acid disorders detected by quantitative amino acid HPLC analysis in Thailand: an eight-year experience","volume":"413","author":"Vatanavicharn","year":"2012","journal-title":"Clin Chim Acta"},{"issue":"4","key":"10.1016\/j.gim.2024.101303_bib21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ymgme.2012.05.023","article-title":"Analysis of gene mutations in Chinese patients with maple syrup urine disease","volume":"106","author":"Yang","year":"2012","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1016\/j.gim.2024.101303_bib22","first-page":"88","article-title":"Liver transplantation in children with inborn errors of metabolism: 30 years experience in NSW, Australia","volume":"60","author":"Elserafy","year":"2021","journal-title":"JIMD Rep"},{"issue":"12","key":"10.1016\/j.gim.2024.101303_bib23","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/adc.57.12.918","article-title":"Outcome of maple syrup urine disease","volume":"57","author":"Naughten","year":"1982","journal-title":"Arch Dis Child"},{"issue":"6","key":"10.1016\/j.gim.2024.101303_bib24","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1542\/peds.68.6.856","article-title":"Outcome of early and long-term management of classical maple syrup urine disease","volume":"68","author":"Clow","year":"1981","journal-title":"Pediatrics"},{"issue":"suppl 3","key":"10.1016\/j.gim.2024.101303_bib25","first-page":"S41","article-title":"Maple syrup urine disease in Thai infants","volume":"91","author":"Pangkanon","year":"2008","journal-title":"J\u00a0Med Assoc Thai"},{"issue":"10","key":"10.1016\/j.gim.2024.101303_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1790","article-title":"The clinico-radiological findings of MSUD in a group of Egyptian children: contribution to early diagnosis and outcome","volume":"9","author":"Mohamed","year":"2021","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"10.1016\/j.gim.2024.101303_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10545-006-0223-1","article-title":"Neuropsychometric outcome predictors for adults with maple syrup urine disease","volume":"29","author":"le Roux","year":"2006","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"3","key":"10.1016\/j.gim.2024.101303_bib28","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ymgme.2016.01.005","article-title":"Living related versus deceased donor liver transplantation for maple syrup urine disease","volume":"117","author":"Feier","year":"2016","journal-title":"Mol Genet Metab"},{"issue":"11","key":"10.1016\/j.gim.2024.101303_bib29","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1002\/ajmg.a.61806","article-title":"Genotype-phenotype correlation of 33 patients with maple syrup urine disease","volume":"182","author":"Khalifa","year":"2020","journal-title":"Am J Med Genet A"},{"issue":"6","key":"10.1016\/j.gim.2024.101303_bib30","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/BF01800467","article-title":"Developmental profile of patients with maple syrup urine disease","volume":"14","author":"Nord","year":"1991","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"suppl 2","key":"10.1016\/j.gim.2024.101303_bib31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10545-008-0859-0","article-title":"Maple syrup urine disease (MSUD)\u2014clinical profile of 47 Filipino patients","volume":"31","author":"Lee","year":"2008","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.gim.2024.101303_bib32","first-page":"43","article-title":"Pre-school neurocognitive and functional outcomes after liver transplant in children with early onset urea cycle disorders, maple syrup urine disease, and propionic acidemia: an inception cohort matched-comparison study","volume":"52","author":"Jain-Ghai","year":"2020","journal-title":"JIMD Rep"},{"issue":"3","key":"10.1016\/j.gim.2024.101303_bib33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jped.2014.08.010","article-title":"Maple syrup urine disease in Brazil: a panorama of the last two decades","volume":"91","author":"Herber","year":"2015","journal-title":"J\u00a0Pediatr (Rio J)"},{"issue":"suppl 2","key":"10.1016\/j.gim.2024.101303_bib34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10545-010-9129-z","article-title":"Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan","volume":"33","author":"Niu","year":"2010","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"3","key":"10.1016\/j.gim.2024.101303_bib35","first-page":"197","article-title":"[Increased mortality and disability in a cohort of Mexican children with maple syrup urine disease]","volume":"143","author":"Ibarra-Gonz\u00e1lez","year":"2007","journal-title":"Gac Med Mex"},{"issue":"3","key":"10.1016\/j.gim.2024.101303_bib36","first-page":"233","article-title":"[Screening for amino acid metabolic disorders of newborns in Zhejiang Province:prevalence, outcome and follow-up]","volume":"46","author":"Huang","year":"2017","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"issue":"2","key":"10.1016\/j.gim.2024.101303_bib37","first-page":"167","article-title":"Leucine tolerance in children with MSUD is not correlated with plasma leucine levels at diagnosis","volume":"36","author":"Kozano\u011flu","year":"2023","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.gim.2024.101303_bib38","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1515\/jpem-2021-0780","article-title":"Organic acidemias in the neonatal period: 30 years of experience in a referral center for inborn errors of metabolism","volume":"35","author":"Unsal","year":"2022","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"issue":"suppl 1","key":"10.1016\/j.gim.2024.101303_bib39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/BF03047366","article-title":"Long term outcome of organic acidurias: survey of 105 French cases (1967-1983)","volume":"7","author":"Rousson","year":"1984","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"3","key":"10.1016\/j.gim.2024.101303_bib40","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/jimd.12318","article-title":"Liver and\/or kidney transplantation in amino and organic acid-related inborn errors of metabolism: an overview on European data","volume":"44","author":"Molema","year":"2021","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"2","key":"10.1016\/j.gim.2024.101303_bib41","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1542\/peds.61.2.262","article-title":"Newborn screening for maple syrup urine disease (branched-chain ketoaciduria)","volume":"61","author":"Naylor","year":"1978","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.gim.2024.101303_bib42","doi-asserted-by":"crossref","first-page":"e1230","DOI":"10.1002\/cl2.1230","article-title":"PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis","volume":"18","author":"Haddaway","year":"2022","journal-title":"Campbell Syst Rev"},{"key":"10.1016\/j.gim.2024.101303_bib43","series-title":"Bewertung des Biasrisikos (Risiko Systematischer Fehler) in Klinischen. Studien: ein Manual f\u00fcr die Leitlinienerstellung","year":"2016"},{"issue":"1","key":"10.1016\/j.gim.2024.101303_bib44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.gim.2024.101303_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2024.108602","article-title":"A\u00a0tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E)","volume":"186","author":"Higgins","year":"2024","journal-title":"Environ Int"},{"issue":"10091","key":"10.1016\/j.gim.2024.101303_bib46","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(17)30818-8","article-title":"Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015","volume":"390","year":"2017","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.gim.2024.101303_bib47","doi-asserted-by":"crossref","first-page":"e1715","DOI":"10.1016\/S2214-109X(22)00429-6","article-title":"Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019","volume":"10","year":"2022","journal-title":"Lancet Glob Health"},{"issue":"10136","key":"10.1016\/j.gim.2024.101303_bib48","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/S0140-6736(18)30994-2","article-title":"Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016","volume":"391","author":"Fullman","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.gim.2024.101303_bib50","first-page":"1","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J\u00a0Stat Softw"},{"issue":"4","key":"10.1016\/j.gim.2024.101303_bib51","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Mental Health"},{"key":"10.1016\/j.gim.2024.101303_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.gim.2024.101303_bib53","first-page":"1","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J\u00a0Stat Softw"},{"issue":"13","key":"10.1016\/j.gim.2024.101303_bib54","first-page":"1","article-title":"lmerTest package: tests in linear mixed effects models","volume":"82","author":"Kuznetsova","year":"2017","journal-title":"J\u00a0Stat Soft"},{"issue":"4","key":"10.1016\/j.gim.2024.101303_bib55","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1172\/JCI67217","article-title":"Biochemical correlates of neuropsychiatric illness in maple syrup urine disease","volume":"123","author":"Muelly","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.gim.2024.101303_bib56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/TACG.S125962","article-title":"Maple syrup urine disease: mechanisms and management","volume":"10","author":"Blackburn","year":"2017","journal-title":"Appl Clin Genet"},{"issue":"3","key":"10.1016\/j.gim.2024.101303_bib57","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/j.semperi.2015.03.002","article-title":"Current status of newborn screening worldwide: 2015","volume":"39","author":"Therrell","year":"2015","journal-title":"Semin Perinatol"},{"issue":"1","key":"10.1016\/j.gim.2024.101303_bib58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/ijns7010015","article-title":"Neonatal screening in Europe revisited: an ISNS perspective on the current state and developments since 2010","volume":"7","author":"Loeber","year":"2021","journal-title":"Int J Neonatal Screen"},{"issue":"2","key":"10.1016\/j.gim.2024.101303_bib59","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41431-023-01469-8","article-title":"A\u00a0framework for evaluating long-term impact of newborn screening","volume":"32","author":"Kalkman","year":"2024","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"10.1016\/j.gim.2024.101303_bib60","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/MOP.0000000000000683","article-title":"Newborn screening in the developing countries","volume":"30","author":"Therrell","year":"2018","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"10.1016\/j.gim.2024.101303_bib61","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ymgme.2018.04.009","article-title":"Universal newborn screening: a roadmap for action","volume":"124","author":"Howson","year":"2018","journal-title":"Mol Genet Metab"},{"issue":"2","key":"10.1016\/j.gim.2024.101303_bib62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.semperi.2009.12.007","article-title":"Newborn screening progress in developing countries\u2014overcoming internal barriers","volume":"34","author":"Padilla","year":"2010","journal-title":"Semin Perinatol"},{"issue":"1","key":"10.1016\/j.gim.2024.101303_bib63","first-page":"35","article-title":"Working Group of the Asia Pacific Society for Human Genetics on Consolidating Newborn Screening Efforts in the Asia Pacific Region. Consolidating newborn screening efforts in the Asia Pacific region: networking and shared education","volume":"3","author":"Padilla","year":"2012","journal-title":"J\u00a0Community Genet"},{"issue":"2","key":"10.1016\/j.gim.2024.101303_bib64","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpam.2014.10.004","article-title":"Barriers to implementing sustainable national newborn screening in developing health systems","volume":"1","author":"Therrell","year":"2014","journal-title":"Int J Pediatr Adolesc Med"},{"issue":"1","key":"10.1016\/j.gim.2024.101303_bib65","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13023-021-01726-3","article-title":"U-IMD: the first Unified European registry for inherited metabolic diseases","volume":"16","author":"Opladen","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.gim.2024.101303_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.832063","article-title":"Rare disease registries are key to evidence-based personalized medicine: highlighting the European experience","volume":"13","author":"K\u00f6lker","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.gim.2024.101303_bib67","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s13063-017-2327-3","article-title":"Establishing core outcome sets for phenylketonuria (PKU) and medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in children: study protocol for systematic reviews and Delphi surveys","volume":"18","author":"Potter","year":"2017","journal-title":"Trials"},{"issue":"2","key":"10.1016\/j.gim.2024.101303_bib68","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-037747","article-title":"Core outcome sets for medium-chain acyl-CoA dehydrogenase deficiency and phenylketonuria","volume":"148","author":"Pugliese","year":"2021","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.gim.2024.101303_bib69","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13023-019-1276-1","article-title":"Outcomes in pediatric studies of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency and phenylketonuria (PKU): a review","volume":"15","author":"Pugliese","year":"2020","journal-title":"Orphanet J Rare Dis"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360024002375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360024002375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T17:05:23Z","timestamp":1736269523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360024002375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1098360024002375"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2024.101303","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of early diagnosis, disease variant, and quality of care on the neurocognitive outcome in maple syrup urine disease: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2024.101303","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.","name":"copyright","label":"Copyright"}],"article-number":"101303"}}